First Bank & Trust’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,159
| Closed | -$94K | – | 383 |
|
|
2022
Q2 | $94K | Sell |
5,159
-1,115
| -18% | -$20.3K | 0.03% | 252 |
|
|
2022
Q1 | $159K | Hold |
6,274
| – | – | 0.05% | 213 |
|
|
2021
Q4 | $174K | Buy |
6,274
+724
| +13% | +$20.1K | 0.07% | 197 |
|
|
2021
Q3 | $179K | Hold |
5,550
| – | – | 0.08% | 180 |
|
|
2021
Q2 | $170K | Buy |
5,550
+282
| +5% | +$8.64K | 0.08% | 188 |
|
|
2021
Q1 | $160K | Buy |
5,268
+1,881
| +56% | +$57.1K | 0.08% | 191 |
|
|
2020
Q4 | $67K | Sell |
3,387
-152
| -4% | -$3.01K | 0.04% | 229 |
|
|
2020
Q3 | $46K | Sell |
3,539
-393
| -10% | -$5.11K | 0.03% | 252 |
|
|
2020
Q2 | $45K | Hold |
3,932
| – | – | 0.03% | 237 |
|
|
2020
Q1 | $56K | Buy |
3,932
+1,751
| +80% | +$24.9K | 0.05% | 216 |
|
|
2019
Q4 | $59K | Buy |
2,181
+1,862
| +584% | +$50.4K | 0.04% | 230 |
|
|
2019
Q3 | $9K | Buy |
+319
| New | +$9K | 0.01% | 313 |
|